Mirati Therapeutics

📍 San Diego, United States🗓 Founded 2013👥 586 employees💰 Last funded Jun 2017
Biotechnology Research🌐 mirati.com
Website LinkedIn
Mirati Therapeutics, Inc. is a clinical-stage biotechnology company whose mission is to discover, design and deliver breakthrough therapies to transform the lives of patients with cancer and their loved ones. The company is relentlessly focused on bringing forward therapies that address areas of high unmet medical need, including lung cancer, and advancing a pipeline of novel therapeutics targeting the genetic and immunological drivers of cancer. Unified for patients, Mirati's vision is to unlock the science behind the promise of a life beyond cancer. For more information about Mirati Therapeutics Inc., visit us at Mirati.com. Read our guidelines for interacting with Mirati on social media here: https://bit.ly/3lFIWB0.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2013
Founded

Investors

1 investor
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Mirati Therapeutics?
Mirati Therapeutics has 1 investor on record on gritt.io, 1 mid-stage.
When did Mirati Therapeutics last raise funding?
The most recent investment in Mirati Therapeutics recorded on gritt.io was in June 2017.
When was Mirati Therapeutics founded?
Mirati Therapeutics was founded in 2013.
What industry is Mirati Therapeutics in?
Mirati Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Mirati Therapeutics based?
Mirati Therapeutics is headquartered in San Diego, United States.